Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

PubMed

Adverse events associated with AveirTM VR leadless pacemaker: A Food and Drug Administration MAUDE database study.

PMID: 37209414 ·

Jalaj Garg, Kuldeep Shah, Rahul Bhardwaj, Tahmeed Contractor, Ravi Mandapati, Mohit K Turagam, Dhanunjaya Lakkireddy

JournalJournal of cardiovascular electrophysiology
Year
PMID37209414

Abstract

Leadless pacemaker (LP) offers an innovative approach for treating bradyarrhythmia, thus avoiding pacemaker pocket and lead-related complications. The Food and Drug Administration (FDA) has recently approved the Aveir™ leadless pacing system (screw-in type LP). We queried the FDA MAUDE database to study the safety profile and assess the types of complications with this relatively novel device technology. A MAUDE database search was conducted on January 20, 2023, for reports received post-FDA app

Official Source

View on PubMed →

Data sourced from PubMed / NCBI. For the full text and most current information, always refer to the official record.

↑